Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Pharmacology and placental transport of 17-hydroxyprogesterone caproate in singleton gestation.

Caritis SN, Sharma S, Venkataramanan R, Hankins GD, Miodovnik M, Hebert MF, Umans JG, Benedetti T, Mattison D, Zajicek A, Fischer D, Jackson A; Eunice Kennedy Shriver National Institute of Child Health and Human Development Obstetrical-Fetal Pharmacology Research Units Network..

Am J Obstet Gynecol. 2012 Nov;207(5):398.e1-8. doi: 10.1016/j.ajog.2012.08.015.

2.

Pharmacokinetics of 17-hydroxyprogesterone caproate in multifetal gestation.

Caritis SN, Sharma S, Venkataramanan R, Rouse DJ, Peaceman AM, Sciscione A, Spong CY, Varner MW, Malone FD, Iams JD, Mercer BM, Thorp JM Jr, Sorokin Y, Carpenter M, Lo J, Ramin S, Harper M; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network..

Am J Obstet Gynecol. 2011 Jul;205(1):40.e1-8. doi: 10.1016/j.ajog.2011.03.028.

3.

Does 17-α-hydroxyprogesterone caproate affect fetal biometry and birth weight in twin pregnancy?

Mulder EJ, Versteegh EM, Bloemenkamp KW, Lim AC, Mol BW, Bekedam DJ, Kwee A, Bruinse HW, Christiaens GC.

Ultrasound Obstet Gynecol. 2013 Sep;42(3):329-34. doi: 10.1002/uog.12486.

4.

Population pharmacokinetics of 17α-hydroxyprogesterone caproate in singleton gestation.

Sharma S, Caritis S, Hankins G, Miodovnik M, Hebert MF, Mattison D, Venkataramanan R.

Br J Clin Pharmacol. 2016 Oct;82(4):1084-93. doi: 10.1111/bcp.12990.

PMID:
27133963
5.

Relationship between 17-hydroxyprogesterone caproate concentrations and gestational age at delivery in twin gestation.

Caritis SN, Simhan HN, Zhao Y, Rouse DJ, Peaceman AM, Sciscione A, Spong CY, Varner MW, Malone FD, Iams JD, Mercer BM, Thorp JM Jr, Sorokin Y, Carpenter M, Lo J, Ramin SM, Harper M; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network..

Am J Obstet Gynecol. 2012 Nov;207(5):396.e1-8. doi: 10.1016/j.ajog.2012.08.001.

6.

The effect of treatment with 17 alpha-hydroxyprogesterone caproate on changes in cervical length over time.

Durnwald CP, Lynch CD, Walker H, Iams JD.

Am J Obstet Gynecol. 2009 Oct;201(4):410.e1-5. doi: 10.1016/j.ajog.2009.07.009.

7.

Route of administration and formulation dependent pharmacokinetics of 17-hydroxyprogesterone caproate in rats.

Shaik IH, Bastian JR, Zhao Y, Caritis SN, Venkataramanan R.

Xenobiotica. 2016;46(2):169-74. doi: 10.3109/00498254.2015.1057547.

8.

Effect of 17-alpha hydroxyprogesterone caproate on cervical length in twin pregnancies.

Lim AC, Schuit E, Papatsonis D, van Eyck J, Porath MM, van Oirschot CM, Hummel P, Hasaart TH, Kleiverda G, de Graaf IM, van Ginkel AA, Mol BW, Bruinse HW.

Ultrasound Obstet Gynecol. 2012 Oct;40(4):426-30. doi: 10.1002/uog.11174.

9.

Prevention of preterm birth with vaginal progesterone or 17-alpha-hydroxyprogesterone caproate: a critical examination of efficacy and safety.

O'Brien JM, Lewis DF.

Am J Obstet Gynecol. 2016 Jan;214(1):45-56. doi: 10.1016/j.ajog.2015.10.934. Review.

PMID:
26558340
10.

Single dose 17 alpha-hydroxyprogesterone caproate in preterm labor: a randomized trial.

Tan PC, King AS, Vallikkannu N, Omar SZ.

Arch Gynecol Obstet. 2012 Mar;285(3):585-90. doi: 10.1007/s00404-011-2026-3.

PMID:
21796421
11.

Progesterone supplementation attenuates hypertension and the autoantibody to the angiotensin II type I receptor in response to elevated interleukin-6 during pregnancy.

Amaral LM, Kiprono L, Cornelius DC, Shoemaker C, Wallace K, Moseley J, Wallukat G, Martin JN Jr, Dechend R, LaMarca B.

Am J Obstet Gynecol. 2014 Aug;211(2):158.e1-6. doi: 10.1016/j.ajog.2014.02.018.

12.

17-hydroxyprogesterone caproate significantly improves clinical characteristics of preeclampsia in the reduced uterine perfusion pressure rat model.

Amaral LM, Cornelius DC, Harmon A, Moseley J, Martin JN Jr, LaMarca B.

Hypertension. 2015 Jan;65(1):225-31. doi: 10.1161/HYPERTENSIONAHA.114.04484.

13.

Progesterone blunts vascular endothelial cell secretion of endothelin-1 in response to placental ischemia.

Kiprono LV, Wallace K, Moseley J, Martin J Jr, Lamarca B.

Am J Obstet Gynecol. 2013 Jul;209(1):44.e1-6. doi: 10.1016/j.ajog.2013.03.032.

14.

Hepatobiliary disposition of 17-OHPC and taurocholate in fetal human hepatocytes: a comparison with adult human hepatocytes.

Sharma S, Ellis EC, Gramignoli R, Dorko K, Tahan V, Hansel M, Mattison DR, Caritis SN, Hines RN, Venkataramanan R, Strom SC.

Drug Metab Dispos. 2013 Feb;41(2):296-304. doi: 10.1124/dmd.112.044891.

15.

The effect of intramuscular progesterone on the rate of cervical shortening.

Pessel C, Moni S, Zork N, Brubaker S, Vink J, Fuchs K, Nhan-Chang CL, Ananth CV, Gyamfi-Bannerman C.

Am J Obstet Gynecol. 2013 Sep;209(3):269.e1-7. doi: 10.1016/j.ajog.2013.05.027.

PMID:
23747451
16.

Effect of endogenous steroid hormones on 17-alpha-hydroxyprogesterone caproate metabolism.

Cuppett CD, Zhao Y, Caritis S, Zhang S, Zhao W, Venkataramanan R.

Am J Obstet Gynecol. 2013 Jan;208(1):86.e1-6. doi: 10.1016/j.ajog.2012.09.021.

PMID:
23063018
17.

Simultaneous quantitation of 17alpha-hydroxyprogesterone caproate, 17alpha-hydroxyprogesterone and progesterone in human plasma using high-performance liquid chromatography-mass spectrometry (HPLC-MS/MS).

Zhang S, Mada SR, Sharma S, Torch M, Mattison D, Caritis S, Venkataramanan R.

J Pharm Biomed Anal. 2008 Dec 1;48(4):1174-80. doi: 10.1016/j.jpba.2008.08.024.

18.

The impact of maternal body mass on the effectiveness of 17 alpha-hydroxyprogesterone caproate.

Ventolini G, Duke J, Po W, Barhan S, Rhea D, Desch C, Istwan N, Stanziano G.

J Reprod Med. 2008 Sep;53(9):667-71.

PMID:
18839818
19.

Relationship between 17-alpha hydroxyprogesterone caproate concentration and spontaneous preterm birth.

Caritis SN, Venkataramanan R, Thom E, Harper M, Klebanoff MA, Sorokin Y, Thorp JM Jr, Varner MW, Wapner RJ, Iams JD, Carpenter MW, Grobman WA, Mercer BM, Sciscione A, Rouse DJ, Ramin S; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network and Obstetric-Fetal Pharmacology Research Units Network..

Am J Obstet Gynecol. 2014 Feb;210(2):128.e1-6. doi: 10.1016/j.ajog.2013.10.008.

20.

Transplacental transfer and metabolism of 17-alpha-hydroxyprogesterone caproate.

Hemauer SJ, Yan R, Patrikeeva SL, Mattison DR, Hankins GD, Ahmed MS, Nanovskaya TN.

Am J Obstet Gynecol. 2008 Aug;199(2):169.e1-5. doi: 10.1016/j.ajog.2007.11.065.

Items per page

Supplemental Content

Support Center